MedPath

Prospective randomised study comparing luteal phase support in in-vitro fertilisation/intracytoplasmic sperm injection patients for three weeks versus seven weeks from day of positive pregnancy test

Completed
Conditions
Infertility patients treated by IVF/ICSI
Pregnancy and Childbirth
Infertility
Registration Number
ISRCTN88722916
Lead Sponsor
The Egyptian IVF-ET Center (Egypt)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

1. Patients undergoing IVF/intra-cytoplasmic sperm injection (ICSI)
2. Aged less than 39 years
3. Having at least three high quality embryos

Exclusion Criteria

Intra-cytoplasmic sperm injection (ICSI) using surgically retrieved sperm.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Miscarriage rate in the first trimester
Secondary Outcome Measures
NameTimeMethod
1. Bleeding episodes in the first trimester<br>2. Adverse reactions to progesterone<br>
© Copyright 2025. All Rights Reserved by MedPath